Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Industry

  • Print
  • Share
  • E-mail
-

PDUFA Documents - Pediatric Exception Repealed

ALL PEDIATRIC SUPPLEMENTS THAT REQUIRE CLINICAL DATA FOR APPROVAL WILL BE REQUIRED TO PAY FEES EFFECTIVE JANUARY 4, 2002. 

This is a result of section 5 of the "Best Pharmaceuticals for Children Act of 2001" signed by the President on January 4, 2002. It repealed the fee exception for pediatric supplements. 

Therefore, if a supplement requires clinical data for approval, even if the supplement is for a new indication in pediatric populations, we would expect a fee, unless the supplement otherwise qualifies for a waiver or exception (e.g., orphan exception).  Further, the exclusion box for pediatric supplements as noted on the user fee cover sheet is no longer applicable.

 

Revised, 1/8/2002, M.D. Jones

-
-